Historique
Rapport
WHO expert committee on drug dependence. 43rd report
Auteur(s) :
OMS / WHO (Organisation mondiale de la santé / World Health Organization) ;
Forty-third meeting of the WHO Expert Committee on Drug Dependence (ECDD) (convened virtually on 12-16 October 2020; coordinated from WHO headquarters in Geneva, Switzerland)
Année
2021
Page(s) :
215 p.
Langue(s) :
Anglais
Éditeur(s) :
Genève : OMS / WHO
Collection :
Rapports techniques / Technical report series, 1034
Domaine :
Autres substances / Other substances ; Drogues illicites / Illicit drugs
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Thésaurus géographique
INTERNATIONAL
Thésaurus mots-clés
RECOMMANDATION
;
CONTROLE DES STUPEFIANTS
;
DROIT INTERNATIONAL
;
CANNABINOIDES
;
OPIOIDES
;
HALLUCINOGENES
;
DROGUES DE SYNTHESE
;
POTENTIEL ADDICTIF
;
BENZODIAZEPINES
;
STIMULANTS
Note de contenu :
CONTENTS:
Introduction.
1. Updates on ECDD meeting recommendations and outcomes.
2. Review of substances:
Hallucinogen
Stimulant
Dissociatives
Synthetic opioid
Synthetic cannabinoid receptor agonists
Benzodiazepines.
Introduction.
1. Updates on ECDD meeting recommendations and outcomes.
2. Review of substances:
Hallucinogen
Stimulant
Dissociatives
Synthetic opioid
Synthetic cannabinoid receptor agonists
Benzodiazepines.
Résumé :
This report presents the recommendations of the forty-third Expert Committee on Drug Dependence (ECDD). The ECDD is responsible for the assessment of psychoactive substances for possible scheduling under the International Drug Control Conventions. The ECDD reviews the therapeutic usefulness, the liability for abuse and dependence, and the public health and social harm of each substance. The ECDD advises the Director-General of WHO to reschedule or to amend the scheduling status of a substance. The Director-General will, as appropriate, communicate the recommendations to the Secretary-General of the United Nations, who will in turn communicate the advice to the Commission on Narcotic Drugs.
This report summarizes the findings of the forty-third meeting at which the Committee reviewed 11 psychoactive substances:
- 5-Methoxy-N,N-diallyltryptamine (5-MeO-DALT)
- 3-Fluorophenmetrazine (3-FPM)
- 3-Methoxyphencyclidine (3-MeO-PCP)
- Diphenidine
- 2-Methoxydiphenidine (2-MeO-DIPHENIDINE)
- Isotonitazene
- MDMB-4en-PINACA
- CUMYL-PEGACLONE
- Flubromazolam
- Clonazolam
- Diclazepam
The report also contains the critical review documents that informed recommendations made by the ECDD regarding international control of those substances.
This report summarizes the findings of the forty-third meeting at which the Committee reviewed 11 psychoactive substances:
- 5-Methoxy-N,N-diallyltryptamine (5-MeO-DALT)
- 3-Fluorophenmetrazine (3-FPM)
- 3-Methoxyphencyclidine (3-MeO-PCP)
- Diphenidine
- 2-Methoxydiphenidine (2-MeO-DIPHENIDINE)
- Isotonitazene
- MDMB-4en-PINACA
- CUMYL-PEGACLONE
- Flubromazolam
- Clonazolam
- Diclazepam
The report also contains the critical review documents that informed recommendations made by the ECDD regarding international control of those substances.